ETC
AUPH icon

Exchange Traded Concepts’s Aurinia Pharmaceuticals AUPH Stock Holding History

Exchange Traded Concepts’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.6K Sell
1,570
-57
-4% -$911 ﹤0.01% 1544
2026
Q1 		$24.1K Buy
+1,627
New +$23.8K ﹤0.01% 1478

Other funds holding AUPH

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM

Exchange Traded Concepts's AUPH Position: Q2 2026 in Review

Exchange Traded Concepts reduced its Aurinia Pharmaceuticals (AUPH) stake by 3.5% in Q2 2026, selling an estimated $911 and leaving 1,570 shares worth $26.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1544.

Exchange Traded Concepts first reported a position in AUPH in Q1 2026 and has held it in 2 quarters since. 42 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Exchange Traded Concepts held 1,570 shares of Aurinia Pharmaceuticals worth $26.6K as of Q2 2026.
  • Exchange Traded Concepts sold 57 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $911.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #1544 holding.
  • Exchange Traded Concepts first reported a position in Aurinia Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 42 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.